Perspectives in Manipulating EVs for Therapeutic Applications: Focus on Cancer Treatment
Extracellular vesicles (EVs) receive special attention from oncologists due to their assumed usefulness as prognostic markers, vaccines to induce anti-cancer immune response, and physiological delivery tools. The latter application, which supports the reduction of side effects of treatment, is still...
Main Authors: | Katarzyna Nazimek, Krzysztof Bryniarski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/13/4623 |
Similar Items
-
OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications
by: Khalid Otmani, et al.
Published: (2022-09-01) -
The Connection between MicroRNAs and Oral Cancer Pathogenesis: Emerging Biomarkers in Oral Cancer Management
by: Ciprian Osan, et al.
Published: (2021-12-01) -
MicroRNA as a Potential Therapeutic Molecule in Cancer
by: Joanna Szczepanek, et al.
Published: (2022-03-01) -
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
by: Atonu Chakrabortty, et al.
Published: (2023-06-01) -
MiRNA Profiles of Extracellular Vesicles Secreted by Mesenchymal Stromal Cells—Can They Predict Potential Off-Target Effects?
by: Timo Z. Nazari-Shafti, et al.
Published: (2020-09-01)